UBS Group Raises WisdomTree (NYSE:WT) Price Target to $14.00

WisdomTree (NYSE:WT - Get Free Report) had its price objective increased by equities researchers at UBS Group from $12.00 to $14.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a "buy" rating on the stock. UBS Group's price target suggests a potential upside of 30.84% from the stock's current price.

Several other equities analysts also recently commented on the company. Northland Securities increased their target price on WisdomTree from $12.00 to $13.50 and gave the company an "outperform" rating in a research report on Monday, July 29th. Craig Hallum raised their price objective on shares of WisdomTree from $12.00 to $15.00 and gave the company a "buy" rating in a report on Monday, July 29th. Keefe, Bruyette & Woods reiterated a "market perform" rating and set a $12.00 target price (up from $11.00) on shares of WisdomTree in a research report on Monday, July 29th. Northcoast Research cut shares of WisdomTree from a "strong-buy" rating to a "hold" rating in a research report on Sunday, September 15th. Finally, Oppenheimer lifted their price target on shares of WisdomTree from $12.00 to $13.00 and gave the stock an "outperform" rating in a report on Monday, July 29th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, WisdomTree currently has an average rating of "Moderate Buy" and an average target price of $12.25.

WisdomTree Price Performance

Shares of WisdomTree stock traded up $0.33 during midday trading on Tuesday, hitting $10.70. 1,732,083 shares of the company traded hands, compared to its average volume of 1,268,099. The firm's fifty day moving average price is $9.92 and its 200-day moving average price is $9.83. The stock has a market cap of $1.62 billion, a price-to-earnings ratio of 15.74 and a beta of 1.43. WisdomTree has a 12 month low of $6.06 and a 12 month high of $12.02. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.18 and a current ratio of 3.01.

WisdomTree (NYSE:WT - Get Free Report) last posted its earnings results on Friday, July 26th. The company reported $0.16 earnings per share for the quarter, topping analysts' consensus estimates of $0.14 by $0.02. WisdomTree had a net margin of 19.72% and a return on equity of 19.22%. The firm had revenue of $107.03 million for the quarter, compared to analysts' expectations of $103.75 million. As a group, sell-side analysts forecast that WisdomTree will post 0.62 earnings per share for the current year.

Hedge Funds Weigh In On WisdomTree

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Victory Capital Management Inc. grew its position in shares of WisdomTree by 92.5% during the 2nd quarter. Victory Capital Management Inc. now owns 1,922,414 shares of the company's stock worth $19,051,000 after buying an additional 923,994 shares during the period. Kornitzer Capital Management Inc. KS bought a new stake in WisdomTree in the second quarter valued at $5,748,000. Acadian Asset Management LLC acquired a new position in shares of WisdomTree during the second quarter valued at about $4,258,000. ClariVest Asset Management LLC bought a new position in shares of WisdomTree during the 1st quarter worth about $3,840,000. Finally, Marshall Wace LLP grew its stake in shares of WisdomTree by 82.3% in the 2nd quarter. Marshall Wace LLP now owns 772,543 shares of the company's stock valued at $7,656,000 after buying an additional 348,850 shares during the period. Institutional investors and hedge funds own 78.64% of the company's stock.

About WisdomTree

WisdomTree, Inc, through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company also licenses its indexes to third parties for proprietary products, as well as offers a platform to promote the use of WisdomTree ETFs in 401(k) plans.